FACTORS OF PROGRESSION OF ARTERIAL HYPERTENSION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Keywords:
type 2 diabetes mellitus, arterial hypertension, progression factors, mortality, risk factors.Abstract
Type 2 diabetes mellitus (T2DM) is associated with a high risk of early mortality and morbidity due to cardiovascular disease (CVD) such as hypertension (AH), stroke and end-stage renal disease. The prevalence of arterial hypertension in patients with diabetes is about twice as high as in patients without diabetes. The incidence of diabetes is growing rapidly and will soon affect 300 million people worldwide, more than half of whom will be hypertensive. Moreover, diabetes mellitus is the most common cause of end-stage renal disease.
Recent studies have found that nearly two-thirds of adults with diabetes are on antihypertensive therapy or have blood pressure >130/80 mmHg. st..
Arterial hypertension is the leading cause of morbidity and mortality among patients with type 2 diabetes associated with cardiovascular disease.
A study of patients with diabetes mellitus showed that the coexistence of hypertension with diabetes mellitus was associated with the risk of death and cardiovascular complications by 44% and 41%, respectively, compared with 7% and 9% in patients with diabetes mellitus. Hypertension is also the biggest cause of high costs for patients with DM. The prevalence of hypertension among patients with DM is higher than in patients without DM.
References
Nouh F, Omar M, Younis M. Prevalence of hypertension among diabetic patients in Benghazi: a study of associated factors. Asian J Med Heal. 2017;6(4):1–11. doi:10.9734/AJMAH/2017/35830
Vargas-uricoechea H, Cáceres-acosta MF. Control of blood pressure and cardiovascular outcomes in type 2 diabetes. Open Med. 2018;13:304–323. doi:10.1515/med-2018-0048
International Diabetes Federation. Eighth Edition 2017. 2017. doi:10.1016/S0140-6736(16)31679-8
Rodrigues JCL, Amadu AM, Dastidar AG, et al. ECG strain pattern in hypertension is associated with myocardial cellular expansion and diffuse interstitial fibrosis: a multi-parametric cardiac magnetic resonance study. Eur Hear J Cardiovasc Imaging. 2017;2017(18):441–450. doi:10.1093/ehjci/jew117
Siddiqui MA, Mittal PK, Brent P, et al. Secondary hypertension and complications: diagnosis and role of imaging. RadioGraphics. 2019;39(4):1036–1055. doi:10.1148/rg.2019180184
Esh H, Agabiti E, France MA, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Hear J. 2018;2018(00):1–98. doi:10.1097/HJH
Fatulloyeva D. S. et al. Evaluation of the effectiveness of thrombolytic therapy in myocardial infarction in the conditions of the samarkand branch of rscemc //Euro-Asia Conferences. – 2021. – Т. 1. – №. 1. – С. 177-182.
Nithish C, Prasad RB, Reddy MRRM. Estimation of risk factors for cardio vascular diseases in urban & semi-urban population: a prospective observational study. International J Med Heal Res. 2019;2019(5):84–86.
Grillo A, Salvi L, Coruzzi P, Paolo Salv GP. Sodium intake and hypertension. Nutrients. 2019;11(1970):1–16. doi:10.3390/nu11091970
Rasuli F. O. et al. Clinical features of ihd course on the background of atrial fibrillation //Euro-Asia Conferences. – 2021. – Т. 1. – №. 1. – С. 195-199.
Williams B, Esh GM, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertension. 2018;36(10):1953–2041. doi:10.1093/eurheartj/ehy339
Owolabi EO, Ter GD, Adeniyi OV, Seekoe E. Social epidemiology of hyp ertension in Buffalo City Metropolitan Municipality (BCMM): cross-sectional study of determinants of prevalence, awareness, treatment and control among South African adults. BMJ Open. 2017;7(6):1–12. doi:10.1136/bmjopen-2016-014349
Tadesse K, Amare H, Hailemariam T, Gebremariam T. Prevalence of hypertension among patients with type 2 diabetes mellitus and its socio demographic factors in Nigist Ellen Mohamed Memorial Hospital. J Diabetes Metab. 2018;9(1):4. doi:10.4172/2155-6156.1000792
Dedefo A, Galgalo A, Jarso G, Mohammed A. Prevalence of hypertension and its management pattern among type 2 diabetic patients attending, Adama Hospital Medical College, Adama. J Diabetes Metab. 2018;9(10):1–8. doi:10.4172/2155-6156.1000808
Kurbanov R. D., Shek A. B., Tashkenbaeva N. F. Effects of atorvastatin and acipimox on the lipid spectrum of blood plasma, endothelial function and a clinical course of unstable angina pectoris //Terapevticheskii Arkhiv. – 2006. – Т. 78. – №. 8. – С. 38-41.
Alice YY. Canadian diabetes association clinical practice guidelines expert committee. Can J Diabetes. 2019;37(2013):1–3. doi:10.1016/j.jcjd.2013.01.009
Mariye T, Girmay A, Tasew H, Teklay G. Determinants of hypertension among diabetic patients in public hospitals of the Central Zone, Tigray, Ethiopia 2018: unmatched case- control study. Pan Afr Med J. 2019;8688:1–12. doi:10.11604/pamj.2019.33.100.17094
American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes d 2019. Diabetes Care. 2019;42(1):13–28. doi: 10.2337/dc19-S002.
Noh J, Chang Y, Park M, Kwon YD, Ryu S. Self-rated health and the risk of incident type 2 diabetes mellitus: A cohort study. Sci Rep Open. 2019;9(3697):1–8. doi:10.1038/s41598-019-40090-y
Waly EH, Hamed MS. Hypertension and dyslipidemia among type II diabetic patients and related risk factors and complications methods. Egypt J Community Med. 2018;36(1):31–43.
Tatsumi Y, Ohkubo T. Hypertension with diabetes mellitus: signi fi cance from an epidemiological perspective for Japanese. Hypertens Res. 2017;(March):1–12. doi:10.1038/hr.2017.67
Asresahegn H, Tadesse F, Beyene E. Prevalence and associated factors of hypertension among adults in Ethiopia: a community based cross sectional study. BMC Res Notes. 2017;2017(10:629):1–8. doi:10.1186/s13104-017-2966-1
Liew SJ, Lee JT, Tan CS, Huat C, Koh G, Müller-Riemenschneider F. Sociodemographic factors in relation to hypertension prevalence, awareness, treatment and control in a multi-ethnic Asian population: a cross- sectional study. BMJ Open. 2019;9(5):1–10. doi:10.1136/bmjopen-2018-025869
Khanam R, Ahmed S, Rahman S, et al. Prevalence and factors associated with hypertension among adults in rural Sylhet district of Bangladesh: a cross- sectional study. BMJ Open. 2019;9(10):1–9. doi:10.1136/bmjopen-2018-026722
Head T, Daunert S, Goldschmidt-Clermont PJ. The aging risk and atherosclerosis: a fresh look at arterial homeostasis. Front Genet. 2017;8(12):1–11. doi:10.3389/fgene.2017.00216
Ames MK, Atkins CE, Pitt B. The renin-angiotensin-aldosterone system and its suppression. J Vet Intern Med. 2019;33(2):363–382. doi:10.1111/jvim.15454
Katakami N. Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus. J Atheroscler Thromb. 2018;25(1):27–39. doi:10.5551/jat.RV17014
Wolfsdorf JI, Glaser N, Agus M, et al. ISPAD clinical practice consensus guidelines ISPAD clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018;19(10):155–177. doi:10.1111/pedi.12701
Khader Y, Batieha A, Jaddou H, et al. Hypertension in Jordan: prevalence, awareness, control, and its associated factors. Int J Hypertens. 2019;2019:1–9. doi:10.1155/2019/3210617
Wang J, Sun W, Wells GA, et al. Differences in prevalence of hypertension and associated risk factors in urban and rural residents of the northeastern region of the People ’ s Republic of China: a cross-sectional study. Plos One. 2018;13(4):1–14.
